Insider · CIK 0001717983
J. Kermit Anderson
Files at ADIL (ADIAL PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
J. Kermit Anderson files SEC Form 4 as director at ADIL (ADIAL PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; J. Kermit Anderson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 7, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +9,185 | $0.00 | $0 | 9,185 | Apr 9, 2026 |
| May 29, 2025 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +28,000 | $0.00 | $0 | 28,000 | Jun 2, 2025 |
Questions about J. Kermit Anderson
Answered from the filings on this page, as of the latest one.
Is J. Kermit Anderson buying or selling?
J. Kermit Anderson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did J. Kermit Anderson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and J. Kermit Anderson has 0.
Where does J. Kermit Anderson file Form 4?
J. Kermit Anderson has filed Form 4 at ADIL (ADIAL PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.